Tech Company Financing Transactions
Helaina Funding Round
Helaina closed a $45 million Series B funding round on 9/25/2024. Investors included Avidity Partners, Barrel Ventures and Ingeborg Investments.
Transaction Overview
Company Name
Announced On
9/25/2024
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to scale the availability of effera�Human Lactoferrin, a novel ingredient to support women's health, active nutrition and healthy aging.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
345 Park Avenue South, 5th Floor
New York, NY 10010
USA
New York, NY 10010
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Helaina was founded in 2019 on the premise that nutrients must be more impactful and multifunctional for all people and the planet. Helaina's technology platform powers a bioactive protein pipeline that will advance human healthspan. Helaina's bioactive proteins will become a new category of nutrients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Katz
Browse more venture capital transactions:
Prev: 9/25/2024: ReSync Bio venture capital transaction
Next: 9/25/2024: Polymarket venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs